NET PROFIT (x1000 EUR)
EMPLOYEES
Swedish Orphan Biovitrum A/S
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
739
|
569
|
581 |
| Total assets |
4,895
|
4,323
|
4,534 |
| Current assets |
4,869
|
4,297
|
4,507 |
| Current liabilities |
648
|
629
|
1,267 |
| Equity capital |
4,247
|
7,388
|
6,534 |
| - share capital |
67
|
67
|
67 |
| Employees (average) |
15
|
15
|
15 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
86.8%
|
170.9%
|
144.1% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
751.4%
|
683.1%
|
355.7% |
| Return on equity (ROE) |
17.4%
|
7.7%
|
8.9% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.